Not logged inPhase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedema
Wang, Zilin; Sun, Junran; Liu, Kun; Tao, Liming; Liu, Qinghuai; Wu, Miaoqin; Lu, Shujie; Deng, Junjie; Li, Li; Qian, Lei; Li, Xiaorong; Sun, Xiaodong .png)
Share.png)
SaveShare Save Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II TrialSun, Junran; Song, Yanping; Gong, Yuanyuan; Tao, Liming; Wang, Hong; Shu, Xiangwen; Wen, Ying; Cui, Ling; Ye, Jian; Lu, Shujie; Deng, Junjie; Li, Haoyu; Xu, Yihua; Qian, Lei; Wu, Zhifeng; Bi, Yanlong; Liu, Qinghuai; Xu, Xiangzhong; Wu, Miaoqin; Zhang, Jinglin; Hao, Jilong; Tong, Jianping; Dai, Hong; Wang, Feng; Zhao, Mingwei; Mao, Junfeng; Li, Chaopeng; He, Tao; Pei, Cheng; Liu, Xiaoling; Wang, Xian; Li, Mingxin; Wang, Wei; Zheng, Qinxiang; Guan, Huaijin; Peng, Hui; Fan, Ke; Zhang, Wenfang; Zhu, Dan; Yu, Songping; Wei, Wenbin; Ding, Lin; Li, Jinying; Lu, Peirong; Yan, Ming; Liu, Wei; Jia, Huixun; Sun, Xiaodong Share Save A Novel Bispecific Fusion Protein Targeting C3b/C4b and VEGF in Patients With nAMD: A Randomized, Open-Label, Phase 1b StudyJia, Huixun; LI, Tong; Sun, Junran; Gong, Yuanyuan; Liu, Haiyun; Wang, Hong; Chen, Jieqiong; Liu, Wenjia; Lu, Shujie; Feng, Liqi; Wan, Qiuchen; Qian, Lei; Wang, Fenghua; Liu, Xiaoling; Sun, Xiaodong Share Save Targeting C3b/C4b and VEGF with a bispecific fusion protein optimized for neovascular age-related macular degeneration therapyYang, Shiqi; Li, Tong; Jia, Huixun; Gao, Min; Li, Yiming; Wan, Xiaoling; Huang, Zhen; Li, Min; Zhai, Yuanqi; Li, Xiaomeng; Yang, Xiaotong; Wang, Tao; Liang, Jian; Gu, Qing; Luo, Xueting; Qian, Lei; Lu, Shujie; Liu, Junjian; Song, Yanping; Wang, Fenghua; Sun, Xiaodong; Yu, Dechao Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
